BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc (Nasdaq – AVDL), Middlefield Banc Corp. (Nasdaq – MBCN), Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated…

BALA CYNWYD, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Avadel Pharmaceuticals plc (Nasdaq – AVDL)

Under the terms of the Merger Agreement, Avadel will be acquired by Alkermes plc (“Alkermes”) (Nasdaq - ALKS) for total transaction consideration of up to $20.00 per share in cash, which values Avadel at approximately $2.1 billion. The investigation concerns whether the Avadel Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/avadel-pharmaceuticals-plc-nasdaq-avdl/.

Middlefield Banc Corp. (Nasdaq – MBCN)

Under the terms of the Merger Agreement, Middlefield will be acquired by Farmers National Banc Corp. (“Farmers”) (Nasdaq - FMNB). Each share of Middlefield common stock will be converted into the right to receive 2.6 shares of Farmers common stock. Based on Farmers’ closing share price of $13.91 on October 20, 2025, the proposed transaction is valued at approximately $299.0 million, or $36.17 per Middlefield share.The investigation concerns whether the Middlefield Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/middlefield-banc-corp-nasdaq-mbcn/.

Heidrick & Struggles International, Inc. (Nasdaq - HSII)

Under the terms of the Merger Agreement, Heidrick & Struggles will be acquired by a consortium of investors led by Advent International (“Advent”) and Corvex Private Equity (“Corvex”) for $59.00 per share in cash, valuing the Company at approximately $1.3 billion. The investigation concerns whether the Heidrick & Struggles Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/heidrick-struggles-international-inc-nasdaq-hsii/.

Comerica Incorporated (NYSE - CMA)

Under the terms of the agreement, Comerica will be acquired by Fifth Third Bancorp (Nasdaq - FITB). Comerica’s stockholders will receive 1.8663 Fifth Third shares for each Comerica share, representing $82.88 per share as of Fifth Third’s closing stock price on October 3, 2025. At close, Fifth Third shareholders will own approximately 73% and Comerica shareholders will own approximately 27% of the combined company. The investigation concerns whether the Comerica Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/comerica-incorporated-nyse-cma/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.